633 related articles for article (PubMed ID: 16149080)
21. Distribution and clinical significance of heparan sulfate proteoglycans in ovarian cancer.
Davies EJ; Blackhall FH; Shanks JH; David G; McGown AT; Swindell R; Slade RJ; Martin-Hirsch P; Gallagher JT; Jayson GC
Clin Cancer Res; 2004 Aug; 10(15):5178-86. PubMed ID: 15297422
[TBL] [Abstract][Full Text] [Related]
22. IGF-I affects glycosaminoglycan/proteoglycan synthesis in breast cancer cells through tyrosine kinase-dependent and -independent pathways.
Mitropoulou TN; Theocharis AD; Nikitovic D; Karamanos NK; Tzanakakis GN
Biochimie; 2004; 86(4-5):251-9. PubMed ID: 15194227
[TBL] [Abstract][Full Text] [Related]
23. [Anders Jahre Prize for young researchers 1993. Syndecan--a regulator of growth factor activities between cells and cell matrix interface].
Jalkanen M
Nord Med; 1994; 109(3):72-3. PubMed ID: 7511221
[TBL] [Abstract][Full Text] [Related]
24. Heparan sulphate proteoglycan expression in human primary liver tumours.
Roskams T; De Vos R; David G; Van Damme B; Desmet V
J Pathol; 1998 Jul; 185(3):290-7. PubMed ID: 9771483
[TBL] [Abstract][Full Text] [Related]
25. Heparan sulfate proteoglycans are increased during skeletal muscle regeneration: requirement of syndecan-3 for successful fiber formation.
Casar JC; Cabello-Verrugio C; Olguin H; Aldunate R; Inestrosa NC; Brandan E
J Cell Sci; 2004 Jan; 117(Pt 1):73-84. PubMed ID: 14627628
[TBL] [Abstract][Full Text] [Related]
26. Heparan and chondroitin sulfate on growth plate perlecan mediate binding and delivery of FGF-2 to FGF receptors.
Smith SM; West LA; Govindraj P; Zhang X; Ornitz DM; Hassell JR
Matrix Biol; 2007 Apr; 26(3):175-84. PubMed ID: 17169545
[TBL] [Abstract][Full Text] [Related]
27. Signaling from across the way: transactivation of VEGF receptors by HSPGs.
Selleck SB
Mol Cell; 2006 May; 22(4):431-2. PubMed ID: 16713570
[TBL] [Abstract][Full Text] [Related]
28. Novel extracellular matrix structures in the neural stem cell niche capture the neurogenic factor fibroblast growth factor 2 from the extracellular milieu.
Kerever A; Schnack J; Vellinga D; Ichikawa N; Moon C; Arikawa-Hirasawa E; Efird JT; Mercier F
Stem Cells; 2007 Sep; 25(9):2146-57. PubMed ID: 17569787
[TBL] [Abstract][Full Text] [Related]
29. [Syndecans in cell adhesion and differentiation].
Brzóska E; Grabowska I
Postepy Biochem; 2005; 51(1):52-9. PubMed ID: 16209342
[TBL] [Abstract][Full Text] [Related]
30. Specific degradation of subendothelial matrix proteoglycans by brain-metastatic melanoma and brain endothelial cell heparanases.
Marchetti D
J Cell Physiol; 1997 Sep; 172(3):334-42. PubMed ID: 9284953
[TBL] [Abstract][Full Text] [Related]
31. Growth factor-induced shedding of syndecan-1 confers glypican-1 dependence on mitogenic responses of cancer cells.
Ding K; Lopez-Burks M; Sánchez-Duran JA; Korc M; Lander AD
J Cell Biol; 2005 Nov; 171(4):729-38. PubMed ID: 16286510
[TBL] [Abstract][Full Text] [Related]
32. Cell surface heparan sulfate proteoglycan and the neoplastic phenotype.
Iozzo RV
J Cell Biochem; 1988 May; 37(1):61-78. PubMed ID: 2968986
[TBL] [Abstract][Full Text] [Related]
33. Growth factors regulate the expression profile of their syndecan co-receptors and the differentiation of mesothelioma cells.
Dobra K; Nurminen M; Hjerpe A
Anticancer Res; 2003; 23(3B):2435-44. PubMed ID: 12894525
[TBL] [Abstract][Full Text] [Related]
34. Proteoglycans and tumor progression: Janus-faced molecules with contradictory functions in cancer.
Tímár J; Lapis K; Dudás J; Sebestyén A; Kopper L; Kovalszky I
Semin Cancer Biol; 2002 Jun; 12(3):173-86. PubMed ID: 12083848
[TBL] [Abstract][Full Text] [Related]
35. Syndecan-1 in B lymphoid malignancies.
Sanderson RD; Børset M
Ann Hematol; 2002 Mar; 81(3):125-35. PubMed ID: 11904737
[TBL] [Abstract][Full Text] [Related]
36. Rerouting of fibroblast growth factor 2 to the classical secretory pathway results in post-translational modifications that block binding to heparan sulfate proteoglycans.
Wegehingel S; Zehe C; Nickel W
FEBS Lett; 2008 Jul; 582(16):2387-92. PubMed ID: 18538671
[TBL] [Abstract][Full Text] [Related]
37. Epigenetic Regulation of the Biosynthesis & Enzymatic Modification of Heparan Sulfate Proteoglycans: Implications for Tumorigenesis and Cancer Biomarkers.
Hull EE; Montgomery MR; Leyva KJ
Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28672878
[TBL] [Abstract][Full Text] [Related]
38. Basic fibroblast growth factor regulates expression of heparan sulfate in human periodontal ligament cells.
Shimabukuro Y; Ichikawa T; Terashima Y; Iwayama T; Oohara H; Kajikawa T; Kobayashi R; Terashima H; Takedachi M; Terakura M; Hashikawa T; Yamada S; Murakami S
Matrix Biol; 2008 Apr; 27(3):232-41. PubMed ID: 18036796
[TBL] [Abstract][Full Text] [Related]
39. Receptor tyrosine kinases and heparan sulfate proteoglycans: Interplay providing anticancer targeting strategies and new therapeutic opportunities.
Lanzi C; Cassinelli G
Biochem Pharmacol; 2020 Aug; 178():114084. PubMed ID: 32526230
[TBL] [Abstract][Full Text] [Related]
40. A spoonful of sugar makes the melanoma go: the role of heparan sulfate proteoglycans in melanoma metastasis.
O'Connell MP; Weeraratna AT
Pigment Cell Melanoma Res; 2011 Dec; 24(6):1133-47. PubMed ID: 21978367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
